<VariationArchive RecordType="classified" VariationID="11476" VariationName="NM_001379110.1(SLC9A6):c.704_709del (p.Glu235_Ser236del)" VariationType="Deletion" Accession="VCV000011476" Version="3" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2021-08-24" MostRecentSubmission="2021-08-24">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="26515" VariationID="11476">
      <GeneList>
        <Gene Symbol="SLC9A6" FullName="solute carrier family 9 member A6" GeneID="10479" HGNC_ID="HGNC:11079" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq26.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="135973837" stop="136047269" display_start="135973837" display_stop="136047269" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="135067582" stop="135129427" display_start="135067582" display_stop="135129427" Strand="+" />
          </Location>
          <OMIM>300231</OMIM>
          <Haploinsufficiency last_evaluated="2020-12-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC9A6">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-12-08" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC9A6">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_001379110.1(SLC9A6):c.704_709del (p.Glu235_Ser236del)</Name>
      <CanonicalSPDI>NC_000023.11:136002170:GTGAAAGTG:GTG</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq26.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="136002171" stop="136002176" display_start="136002171" display_stop="136002176" variantLength="6" positionVCF="136002170" referenceAlleleVCF="GGTGAAA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="135084330" stop="135084335" display_start="135084330" display_stop="135084335" variantLength="6" positionVCF="135084329" referenceAlleleVCF="GGTGAAA" alternateAlleleVCF="G" />
      </Location>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.135084333_135084338del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.135084333_135084338del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.136002174_136002179del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.136002174_136002179del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_017160.1" sequenceAccession="NG_017160" sequenceVersion="1" change="g.21748_21753del">
            <Expression>NG_017160.1:g.21748_21753del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001042537.2" sequenceAccession="NM_001042537" sequenceVersion="2" change="c.860_865del">
            <Expression>NM_001042537.2:c.860_865del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001036002.1" sequenceAccession="NP_001036002" sequenceVersion="1" change="p.Glu287_Ser288del">
            <Expression>NP_001036002.1:p.Glu287_Ser288del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001177651.2" sequenceAccession="NM_001177651" sequenceVersion="2" change="c.704_709del">
            <Expression>NM_001177651.2:c.704_709del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001171122.1" sequenceAccession="NP_001171122" sequenceVersion="1" change="p.Glu235_Ser236del">
            <Expression>NP_001171122.1:p.Glu235_Ser236del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001330652.2" sequenceAccession="NM_001330652" sequenceVersion="2" change="c.608_613del">
            <Expression>NM_001330652.2:c.608_613del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001317581.1" sequenceAccession="NP_001317581" sequenceVersion="1" change="p.Glu203_Ser204del">
            <Expression>NP_001317581.1:p.Glu203_Ser204del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001379110.1" sequenceAccession="NM_001379110" sequenceVersion="1" change="c.704_709del" MANESelect="true">
            <Expression>NM_001379110.1:c.704_709del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001366039.1" sequenceAccession="NP_001366039" sequenceVersion="1" change="p.Glu235_Ser236del">
            <Expression>NP_001366039.1:p.Glu235_Ser236del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006359.3" sequenceAccession="NM_006359" sequenceVersion="3" change="c.764_769del">
            <Expression>NM_006359.3:c.764_769del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006350.1" sequenceAccession="NP_006350" sequenceVersion="1" change="p.Glu255_Ser256del">
            <Expression>NP_006350.1:p.Glu255_Ser256del</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001822" Type="inframe_deletion" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA10602351" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="300231.0001" DB="OMIM" />
        <XRef Type="rs" ID="886037619" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001379110.1(SLC9A6):c.704_709del (p.Glu235_Ser236del) AND Christianson syndrome" Accession="RCV000012231" Version="13">
        <ClassifiedConditionList TraitSetID="3135">
          <ClassifiedCondition DB="MedGen" ID="C2678194">Christianson syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2009-10-15" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2009-10-15" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2021-08-24" MostRecentSubmission="2021-08-24">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">18342287</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19619532</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3135" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5500" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">SLC9A6-Related Syndromic Mental Retardation</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE</ElementValue>
                <XRef Type="MIM" ID="300243" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300231.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300231.0001" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300231.0004" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300231.0007" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300231.0003" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300231.0002" DB="OMIM" />
                <XRef Type="Allelic variant" ID="300231.0005" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Christianson syndrome</ElementValue>
                <XRef ID="306361" DB="GeneTests" />
                <XRef ID="Christianson+Syndrome/1400" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010278" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MRXS Christianson</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Angelman-like syndrome X-linked</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation microcephaly epilepsy and ataxia syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked mental retardation, syndromic, Christianson type</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">MRXSCH</ElementValue>
                <XRef Type="MIM" ID="300243" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Christianson syndrome (referred to as CS in this GeneReview), an X-linked disorder, is characterized in males by cognitive dysfunction, behavioral disorder, and neurologic findings (e.g., seizures, ataxia, postnatal microcephaly, and eye movement abnormalities). Males with CS typically present with developmental delay, later meeting criteria for severe intellectual disability (ID). Behaviorally, autism spectrum disorder and hyperactivity are common, and may resemble the behaviors observed in Angelman syndrome. Hypotonia and oropharyngeal dysphagia in infancy may result in failure to thrive. Seizures, typically beginning before age three years, can include infantile spasms and tonic, tonic-clonic, myoclonic, and atonic seizures. Subsequently, regression (e.g., loss of ambulation and ability to feed independently) may occur. Manifestations in heterozygous females range from asymptomatic to mild ID and/or behavioral issues.</Attribute>
                <XRef ID="NBK475801" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10572" />
                <XRef ID="10572" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29334451</ID>
                <ID Source="BookShelf">NBK475801</ID>
              </Citation>
              <XRef ID="85278" DB="Orphanet" />
              <XRef ID="C2678194" DB="MedGen" />
              <XRef ID="MONDO:0010278" DB="MONDO" />
              <XRef Type="MIM" ID="300243" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="32465" SubmissionDate="2021-08-20" DateLastUpdated="2021-08-24" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300231.0001_INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE" title="SLC9A6, 6-BP DEL, NT764_INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE" />
        <ClinVarAccession Accession="SCV000032465" DateUpdated="2021-08-24" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2009-10-15">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 3 affected males from a Norwegian family with the Christianson type of X-linked syndromic intellectual developmental disorder (MRXSCH; 300243), Gilfillan et al. (2008) identified a 6-bp deletion in the SLC9A6 gene, resulting in the loss of 2 highly conserved residues from the Na+/H+ exchanger domain of the protein. Unaffected carrier females also carried the deletion.</Attribute>
              <Citation>
                <ID Source="PubMed">18342287</ID>
              </Citation>
              <XRef DB="OMIM" ID="300243" Type="MIM" />
            </ObservedData>
            <ObservedData>
              <Attribute Type="Description">The 6-bp deletion (764_769del) results in the deletion of glu255 and ser256 in a highly conserved region of transmembrane domain-7 of the SLC9A6 protein. In HeLa cells, Roxrud et al. (2009) found that the 6-bp deletion mutant protein was unstable and rapidly degraded. The mutant protein accumulated in the ER after synthesis and did not localize to recycling endosomes, as did the wildtype protein. However, some mutant protein was found in early endosomes via a dynamin (DNM1; 602377)-dependent mechanism. Degradation of the mutant protein occurred by 2 mechanisms: the ER-associated proteosomal pathway and, for those mutant proteins that escape the ER, ubiquitination and targeting to lysosomes.</Attribute>
              <Citation>
                <ID Source="PubMed">19619532</ID>
              </Citation>
              <XRef DB="OMIM" ID="602377" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC9A6" />
          </GeneList>
          <Name>SLC9A6, 6-BP DEL, NT764</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">6-BP DEL, NT764</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300231.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="32465" TraitType="Disease" MappingType="Name" MappingValue="INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE" MappingRef="Preferred">
        <MedGen CUI="C2678194" Name="Christianson syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

